
Company Performance - Benitec Biopharma Limited (BNTC) has returned 23.6% year-to-date, outperforming the Medical sector, which has lost about 4.8% on average [4] - The Zacks Consensus Estimate for BNTC's full-year earnings has increased by 19.7% over the past quarter, indicating improving analyst sentiment [3] Industry Ranking - Benitec Biopharma Limited is part of the Medical - Biomedical and Genetics industry, which includes 503 companies and currently ranks 72 in the Zacks Industry Rank [5] - The Medical - Biomedical and Genetics industry has lost an average of 4.2% so far this year, showing that BNTC is performing better than its industry peers [5] Sector Context - The Medical sector includes 999 companies and is currently ranked 4 in the Zacks Sector Rank, which evaluates sectors based on the average Zacks Rank of individual companies [2] - Another outperforming stock in the Medical sector is Delcath Systems, Inc. (DCTH), which has returned 33.6% year-to-date [4]